// App-Quantinova.ai

Su1004 : Drug Resistance, Basal Core Promoter and Pre-Core Stop Mutations in a Large Cohort of North American Children With Hepatitis B: Results for the Pediatric Cohort Study of the NIDDK-Sponsored Hepatitis B Research Network (HBRN)

Researchers

Presenter

  • Simon Ling

Principal Investigators

  • Yona K. Cloonan

  • Kathleen B. Schwarz

  • Karen F. Murray

  • Philip Rosenthal

  • Noberto Rodriguez-baez

  • Sarah J. Schwarzenberg

  • Jeffrey Teckman

Medical Centers

  • Johns Hopkins, Baltimore, MD

  • Dept. of Pediatrics, University of Texas Southwestern, Dallas, TX

  • University of California, San Francisco, San Francisco, CA

  • Biostatistics, Washington University, St. Louis, MO

  • Division of Biostatistics, University of Minnesota, Minneapolis, MN

  • University of Toronto, Toronto, ON, Canada

  • Pediatrics, University of Washington, Seattle, WA

  • Epidemiology, Univ of Pittsburgh, Pittsburgh, PA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Hepatitis B

Biomarkers

  • G1764A

  • Hepatitis B e antigen

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved